Zero concentrations – all samples – full replicate [RSABE / ABEL]

posted by jag009  – NJ, 2014-04-07 18:18 (4055 d 01:51 ago) – Posting: # 12788
Views: 13,430

Hi Luv and Pash,

❝ ❝ Our main concern is how to handle such incomplete data statistically in scaled average (full/partial replicate) design study :confused::confused:


❝ IMHO, if your only concern is the data handling and stats, best option is to go for Controlled corresponence with FDA.


The implication / sensitivity analysis might have worked with NDA group. With ANDA group it might not (never hurt to ask). ANDA reviewers are usually more strict...

John

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,671 registered users;
182 visitors (0 registered, 182 guests [including 9 identified bots]).
Forum time: 20:10 CEST (Europe/Vienna)

Only dead fish go with the current.    Scuba divers' proverb

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5